Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Axsome Therapeutics, Inc. AXSM

Set alert

Price alert · AXSM

All alert types
136.01 USD 0.00 0.00%

At close

138.50 +2.49 +1.83%

Pre-market · Nov 3, 8:47 AM ET

Bid
135.81 × 2
Ask
136.01 × 1
123.00 Day range 138.03
123.00 52-week range 260.19
YTD
-25.53%
1 year
+0.19%
Open
137.15
Prev close
136.01
Mkt cap
7.15B
Vol
2.72M
Avg vol
810.47K
EPS
-3.03
P/E
0.00
Div yield
0.00%
More statistics
Low
123.00
High
138.03
Forward P/E
32.37
Beta
0.83
Short ratio
3.67
Inst. own
74.49%
Dividend
0.00
Ex-div date
Earnings
Feb 22, 2027
50-d avg
184.76
200-d avg
199.33
1y target
277.86

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 3, 2025Earnings: -0.94; estimate -0.82; surprise -14.63%
  • May 4, 2026Earnings: -1.26; estimate -0.85; surprise -48.24%
  • Nov 2, 2026Earnings: -0.25; estimate -0.63425; surprise 60.58%
Signals (41)
NameDateAgo
SMA: BearishNov 2, 202617 hours ago
MACD: Sell SignalOct 1, 20261 month ago
SMA: BearishSep 1, 20262 months ago
RSI: OverboughtApr 1, 20267 months ago
RSI: OverboughtNov 1, 20251 year ago
SMA: BullishAug 1, 20251 year ago
SMA: BearishJul 1, 20251 year ago
RSI: OverboughtFeb 1, 20251 year ago
MACD: Buy SignalJul 1, 20242 years ago
SMA: BullishJun 1, 20242 years ago
MACD: Sell SignalMay 1, 20242 years ago
SMA: BearishApr 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishSep 1, 20233 years ago
SMA: BullishNov 1, 20224 years ago
SMA: BearishSep 1, 20224 years ago
SMA: BullishAug 1, 20224 years ago
MACD: Buy SignalAug 1, 20224 years ago
SMA: BullishJun 1, 20224 years ago
SMA: BearishApr 1, 20224 years ago

Newest 20 of 41.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 277.86 +104.3% upside
Target (low)
238.00
Target (mean)
277.86
Target (high)
380.00
Ratings (0m) 22 21 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy18
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 22
  • 1 month ago 22
  • 2 months ago 21

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

AXSM analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.63886-1.00 – -0.41-0.94+32.0%249.19M+45.7%13
Next quarter-0.13774-0.55 – 0.43-0.56+75.4%289.73M+47.8%11
Current year-2.99-3.79 – -2.28-3.47+13.9%949.60M+48.7%13
Next year4.020.37 – 7.84-2.99+234.3%1.51B+59.3%12

Upgrades and downgrades

The latest rating changes

AXSM analyst upgrades and downgrades
DateFirmActionFromTo
Oct 26, 2026Piper SandlerMaintainedOverweightOverweight
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Sep 29, 2026Deutsche BankMaintainedBuyBuy
Sep 25, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Sep 23, 2026Truist SecuritiesMaintainedBuyBuy
Sep 18, 2026Piper SandlerReiteratedOverweightOverweight
Aug 31, 2026HC Wainwright & Co.ReiteratedBuyBuy
Aug 12, 2026MizuhoMaintainedOutperformOutperform
Aug 11, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Aug 11, 2026RBC CapitalMaintainedOutperformOutperform
Aug 11, 2026GuggenheimMaintainedBuyBuy
Aug 11, 2026Wells FargoMaintainedOverweightOverweight
Aug 11, 2026NeedhamMaintainedBuyBuy
Jul 31, 2026MizuhoMaintainedOutperformOutperform
Jul 21, 2026BMO CapitalInitiated—Outperform
Jul 15, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 8, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jul 7, 2026RBC CapitalMaintainedOutperformOutperform
Jun 17, 2026TD CowenMaintainedBuyBuy
May 5, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
May 5, 2026RBC CapitalMaintainedOutperformOutperform
May 5, 2026Wells FargoMaintainedOverweightOverweight
May 5, 2026GuggenheimMaintainedBuyBuy
May 5, 2026MizuhoMaintainedOutperformOutperform
May 5, 2026BairdMaintainedOutperformOutperform
May 5, 2026HC Wainwright & Co.MaintainedBuyBuy
May 5, 2026NeedhamMaintainedBuyBuy
May 4, 2026JefferiesMaintainedBuyBuy
May 4, 2026HC Wainwright & Co.MaintainedBuyBuy
May 1, 2026NeedhamMaintainedBuyBuy